Weigao Blood Purification plans to acquire 100% equity of Weigao Purui, and trading will be suspended from October 20
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Weigao Blood Purification announced that the company is planning to acquire 100% equity of Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. (hereinafter referred to as "Weigao Purui" or "the target company") through the issuance of shares. Upon the company's application, the company's stock will be suspended from trading starting from October 20, 2025 (Monday), and the suspension is expected to last no more than 10 trading days
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments